Info
13F History
Schedule 13D/G History
Ownership

Paradigm Biocapital Advisors LP - Significant Ownership

Signature - Title: David Kim - Chief Operating Officer and Chief Compliance Officer
Location: New York, NY
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Paradigm Biocapital Advisors LP.

Significant Ownership of Paradigm Biocapital Advisors LP

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
OLMA	Olema Pharmaceuticals, Inc.	Common Stock, $0.0001 par value per share	9.99%	$27.9M		7.43M		Paradigm BioCapital Advisors LP	Dec 31, 2024
JANX	Janux Therapeutics, Inc.	Common Stock, $0.001 par value per share	6%	$94.9M		3.52M		Paradigm BioCapital Advisors LP	Dec 31, 2024
LENZ	LENZ Therapeutics, Inc.	Common Stock, $0.00001 par value per share	5.2%	$36.5M		1.42M		Paradigm BioCapital Advisors LP	Mar 20, 2025
MRUS	Merus N.V.	Common Shares, EUR0.09 nominal value per share	5.1%	$150M		3.55M		Paradigm BioCapital Advisors LP	Apr 3, 2025
EWTX	Edgewise Therapeutics, Inc.	Common Stock, $0.0001 par value per share	5%	$104M		4.74M		Paradigm BioCapital Advisors LP	Jan 27, 2025
COGT	Cogent Biosciences, Inc.	Common Stock, $0.001 par value per share	5%	$33.3M		5.56M		Paradigm BioCapital Advisors LP	Feb 5, 2025
KURA	Kura Oncology, Inc.	Common Stock, $0.0001 par value per share	0%	$0		0		Paradigm BioCapital Advisors LP	Dec 31, 2024

Showing 1 to 7 of 7 entries

Schedules 13D/G Reported by Paradigm Biocapital Advisors LP:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.